Loading companies…
Loading companies…
Canada · Biotech · Healthtech
Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | CA$2.6M | Canadian Glycomics Network — Role not disclosedChiefswood Private Capital Inc. — Role not disclosedOntario Centre of Innovation — Role not disclosedToronto Innovation Acceleration Partners — Role not disclosed |